Research Use Only - Not for human consumption. 18+ only.
AGrade ALarge human randomised controlled trials or FDA/major-authority approvedFDA ApprovedFDA ApprovedApproved by the US Food and Drug Administration for at least one indicationGrowth Hormone SecretagoguesSubcutaneous

Lenomorelin

Also known as: RC-1291, Ghrelin mimetic

Synthetic form of the native ghrelin peptide. A potent appetite stimulant that regulates energy balance and stimulates growth hormone release. Research compound for metabolic studies.

Beginner Basics

Plain-English guide to Lenomorelin

What it does

Lenomorelin mimics a natural hunger hormone in your body. Researchers study it because it signals your body to release growth hormone and increase appetite, which may help with energy and muscle maintenance.

Typical dose

Researchers typically use 1-5 micrograms per kilogram of body weight, injected under the skin. The exact dose depends on the specific research protocol being followed.

When to inject

Most research uses it in the morning or before meals, though timing can vary by protocol. Inject it consistently at the same time each day.

Storage

Keep the dry powder in a freezer at -20°C until you mix it. Once mixed with liquid, store it in a regular refrigerator between 2-8°C and keep it away from direct light.

First-timer tip

Start at the lower end of the dose range (1 mcg/kg) and only increase if needed, since this peptide can cause strong appetite effects that some find uncomfortable at higher doses.

Research Status

AGrade ALarge human randomised controlled trials or FDA/major-authority approvedFDA ApprovedFDA ApprovedApproved by the US Food and Drug Administration for at least one indication

Preclinical/Research Phase

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Stimulates growth hormone secretion
Increases appetite and food intake
Enhances energy expenditure
Supports lean muscle mass
Regulates metabolic rate
Improves gastric motility
Promotes ghrelin signaling pathways

Side Effects

Increased appetite and food intake
CommonMild

Expected pharmacological effect of ghrelin agonism. Occurs within 30–60 minutes of administration. Typically resolves as the peptide is metabolized.

Transient increase in cortisol
CommonMild

Ghrelin signaling can transiently elevate cortisol levels. Effect is usually mild and self-resolving. Monitor in protocols involving stress-sensitive endpoints.

Increased heart rate
UncommonMild

May occur due to sympathomimetic effects of ghrelin signaling. Typically mild and transient. Monitor vital signs in research protocols.

Flushing or facial warmth
UncommonMild

Reported in some research subjects. Usually resolves within 15–30 minutes. Related to vasodilatory effects of ghrelin.

Injection site reactions
UncommonMild

Localized erythema, swelling, or mild discomfort at the injection site. Minimize by rotating injection sites and using proper aseptic technique. Usually resolves within 24 hours.

Headache
UncommonMild

Reported in some research protocols. Typically mild and transient. May be related to changes in intracranial pressure or metabolic effects.

Nausea
RareMild

Uncommon but reported in some subjects. Usually mild and self-resolving. May be related to rapid changes in appetite signaling.

Lipodystrophy at injection sites
UncommonModerate

Localized fat loss or thickening can occur with repeated injections at the same site. Prevent by rotating injection sites systematically and spacing injections at least 1 inch apart.

Hyperglycemia
RareModerate

Ghrelin can transiently increase blood glucose in some individuals. Monitor glucose levels in research protocols, especially in subjects with metabolic dysfunction. Effect is usually mild and reversible.

Dosing Reference

ParameterValue
Dose range1-5 mcg/kg
Frequency, timing and route - members only

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2-8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Lenomorelin (RC-1291) is a synthetic ghrelin receptor agonist that mimics the action of native ghrelin, a hormone produced primarily in the stomach. It binds to the growth hormone secretagogue receptor (GHSR-1a) on the hypothalamus and anterior pituitary, triggering the release of growth hormone and stimulating appetite through central nervous system pathways. The peptide also enhances gastric motility and regulates energy homeostasis by modulating metabolic rate and nutrient utilization.

Pathways and mechanism detail available to members

Track your Lenomorelin research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Lenomorelin is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.